US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 1.120
  • -0.050-4.27%
Close Jul 2 16:00 ET
42.03MMarket Cap-216P/E (TTM)

BioXcel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q1
Stock NameRevenueRatio
Product revenue, net582K100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States1.38M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg